Korro Bio, Inc. Basic Shares Outstanding (Weighted Average)
Korro Bio, Inc. (KRRO) reported Basic Shares Outstanding (Weighted Average) of 17.62 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Korro Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 17.62M shares, a 87.62% increase year-over-year.
- Korro Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.60M shares, a 23.60% increase year-over-year.
- Korro Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 9.42M shares, a 0.51% increase year-over-year.
- Korro Bio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 9.39M shares, a 0.95% increase year-over-year.
- Korro Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 9.40M shares, a 5.32% increase from fiscal 2024.
- Korro Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 8.92M shares, a 483.30% increase from fiscal 2023.
- Korro Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.53M shares, a 499.32% increase from fiscal 2022.
- Korro Bio, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 255.18K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 17.62M shares 10-Q · filed 2026-08-06 | 14.63M shares 10-Q · filed 2026-08-06 | 12.88M shares derived: average of 3 quarters · filed 2026-08-06 | 12.01M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | 11.60M shares 10-Q · filed 2026-05-07 | 10.51M shares derived: average of 2 quarters · filed 2026-05-07 | 10.14M shares derived: average of 3 quarters · filed 2026-05-07 | 9.95M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | 9.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 9.40M shares derived: average of 2 quarters · filed 2026-03-12 | 9.40M shares derived: average of 3 quarters · filed 2026-08-06 | 9.40M shares 10-K · filed 2026-03-12 | ||
| 2025-09-30 | 9.39M shares 10-Q · filed 2025-11-12 | 9.39M shares derived: average of 2 quarters · filed 2026-08-06 | 9.39M shares 10-Q · filed 2025-11-12 | 9.38M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | 9.39M shares 10-Q · filed 2026-08-06 | 9.39M shares 10-Q · filed 2026-08-06 | 9.38M shares derived: average of 3 quarters · filed 2026-08-06 | 9.36M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | 9.38M shares 10-Q · filed 2026-05-07 | 9.38M shares derived: average of 2 quarters · filed 2026-05-07 | 9.35M shares derived: average of 3 quarters · filed 2026-05-07 | 9.26M shares derived: average of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | 9.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 9.34M shares derived: average of 2 quarters · filed 2026-03-12 | 9.22M shares derived: average of 3 quarters · filed 2026-03-12 | 8.92M shares 10-K · filed 2026-03-12 | ||
| 2024-09-30 | 9.30M shares 10-Q · filed 2025-11-12 | 9.14M shares derived: average of 2 quarters · filed 2025-11-12 | 8.77M shares 10-Q · filed 2025-11-12 | 7.90M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 8.99M shares 10-Q · filed 2025-08-12 | 8.50M shares 10-Q · filed 2025-08-12 | 7.43M shares derived: average of 3 quarters · filed 2025-08-12 | 5.64M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 8.02M shares 10-Q · filed 2025-05-07 | 6.65M shares derived: average of 2 quarters · filed 2025-05-07 | 4.53M shares derived: average of 3 quarters · filed 2025-05-07 | 3.47M shares derived: average of 4 quarters · filed 2025-05-07 | ||
| 2023-12-31 | 5.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 2.78M shares derived: average of 2 quarters · filed 2025-03-18 | 1.95M shares derived: average of 3 quarters · filed 2025-03-18 | 1.53M shares 10-K · filed 2025-03-18 | ||
| 2023-09-30 | 284.16K shares 10-Q · filed 2024-11-12 | 36.92M shares 10-Q · filed 2023-11-02 | 280.32K shares derived: average of 2 quarters · filed 2024-11-12 | 277.43K shares 10-Q · filed 2024-11-12 | 36.01M shares 10-Q · filed 2023-11-02 | -25.80M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 276.48K shares 10-Q · filed 2024-08-13 | 274.01K shares 10-Q · filed 2024-08-13 | -34.49M shares derived: average of 3 quarters · filed 2024-08-13 | -17.06M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 271.52K shares 10-Q · filed 2024-05-14 | -51.87M shares derived: average of 2 quarters · filed 2024-05-14 | -22.83M shares derived: average of 3 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -104.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -34.39M shares derived: average of 2 quarters · filed 2024-03-26 | 255.18K shares 10-K · filed 2024-03-26 | |||
| 2022-09-30 | 35.25M shares 10-Q · filed 2023-11-02 | 35.01M shares 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |